ONCOLYTICS BIOTECH

Serial Number 86255705
Registration 4784261
800

Registration Progress

Application Filed
Apr 17, 2014
Under Examination
Approved for Publication
May 19, 2015
Published for Opposition
May 19, 2015
Registered
Aug 4, 2015

Trademark Image

ONCOLYTICS BIOTECH

Basic Information

Serial Number
86255705
Registration Number
4784261
Filing Date
April 17, 2014
Registration Date
August 4, 2015
Published for Opposition
May 19, 2015
Renewal Date
August 4, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
800
Status Date
Nov 14, 2025
Registration
Registered
Classes
005

Rights Holder

Oncolytics Biotech Inc.

03
Address
Suite 804
322 - 11th Avenue SW
Calgary, Alberta T2R 0C5
CA

Ownership History

Oncolytics Biotech Inc.

Original Applicant
03
Calgary, Alberta CA

Oncolytics Biotech Inc.

Owner at Publication
03
Calgary, Alberta CA

Oncolytics Biotech Inc.

Original Registrant
03
Calgary, Alberta CA

Legal Representation

Attorney
John P. McCormick

USPTO Deadlines

Next Deadline
3482 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on renewal date 20150804)
Due Date
August 04, 2035
Grace Period Ends
February 04, 2036

Application History

37 events
Date Code Type Description Documents
Nov 14, 2025 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
Nov 14, 2025 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
Nov 14, 2025 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
Nov 14, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 29, 2025 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Aug 4, 2024 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Nov 3, 2021 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Nov 3, 2021 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 3, 2021 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Jul 28, 2021 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 4, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Aug 4, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 19, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 19, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 29, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 11, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Apr 11, 2015 ALIE A ASSIGNED TO LIE Loading...
Mar 23, 2015 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 23, 2015 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Mar 23, 2015 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2015 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Mar 23, 2015 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Oct 27, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 27, 2014 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 27, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 12, 2014 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Aug 26, 2014 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Aug 9, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 5, 2014 ALIE A ASSIGNED TO LIE Loading...
Jul 28, 2014 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 28, 2014 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 28, 2014 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 28, 2014 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Jul 28, 2014 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 28, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
May 2, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 21, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Housemark for pharmaceutical products; pharmaceutical preparations for use in the treatment of cancer
First Use Anywhere: Jul 21, 2000
First Use in Commerce: Nov 14, 2005

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOTECH"